Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

Idenix Pharmaceuticals Inc. (IDIX)

-NasdaqGS
24.42 Down 0.03(0.12%) 4:00PM EDT
|After Hours : 24.42 0.00 (0.00%) 5:04PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2013Jun 30, 2013Mar 31, 2013Dec 31, 2012
Total Revenue 19   112   852   327  
Cost of Revenue15  368  332  352  
Gross Profit 4   (256) 520   (25)
Operating Expenses
Research Development21,673  19,779  24,008  17,578  
Selling General and Administrative8,630  9,141  7,535  7,365  
Non Recurring3,900   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (34,199) (29,176) (31,023) (24,968)
Income from Continuing Operations
Total Other Income/Expenses Net244  257  271  2,152  
Earnings Before Interest And Taxes(33,955)(28,919)(30,752)(22,816)
Interest Expense -   -   -   -  
Income Before Tax(33,955)(28,919)(30,752)(22,816)
Income Tax Expense -   -  1  (90)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(33,955)(28,919)(30,753)(22,726)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (33,955) (28,919) (30,753) (22,726)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (33,955) (28,919) (30,753) (22,726)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.